The risk of developing venous thromboembolism (VTE) is four to seven times higher in patients with cancer than in those without. At JADPRO Live 2022, presenters discussed risk factors and assessing patients for VTE, as well as how to protect patients against VTE in both the inpatient and outpatient clinic settings. They reviewed selecting an appropriate anticoagulation treatment, including the choice of agent and duration of treatment for the patient with cancer, and finally the steps needed to assess and treat patients experiencing therapeutic anticoagulation failure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184841 | PMC |
| http://dx.doi.org/10.6004/jadpro.2023.14.3.6 | DOI Listing |
Publication Analysis
Top Keywords
patients vte
8
cancer-associated thrombosis
4
thrombosis risk
4
risk assessment
4
assessment prevention
4
prevention treatment
4
treatment risk
4
risk developing
4
developing venous
4
venous thromboembolism
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!